Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cytogen, Inc.
Songpa-gu, Seoul, South Koreacytogenlab.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Cytogen has developed a proprietary platform for isolating and analyzing live circulating tumor cells from blood samples. This enables non-invasive cancer diagnostics, companion diagnostics development, drug response monitoring, biomarker discovery/validation, and recurrence prediction. The company collaborates with major hospitals and pharmaceutical companies globally.
- Therapeutic areas
- Oncology
- Modalities
- Liquid biopsy technology based on Circulating Tumor Cells (CTCs)
- Industry
- Molecular Diagnostics
02
Partnerships
Thermo Fisher Scientific (antibody development project)Daiichi Sankyo (multiple contracts)Samsung Seoul Hospital [multiple contracts/platform supply contract], Yonsei Severance Hospital, Seoul St. Mary’s Hospital [clinical collaborations], National Cancer Center Korea [biomarker discovery], ABL Bio [biomarker collaboration], CMIC Japan [marketing partnership].
Beyond the preview
Go deeper on Cytogen, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cytogen, Inc..